Numerous molecular mechanisms have been proposed to contribute to the development of DCM, including altered myocardial insulin signalling, mitochondrial dysfunction, increased oxidative stress, autophagy and dysregulation of Ca2+ handling,1 which result in cardiomyocyte necrosis, cardiac remodelling and both diastolic and systolic dysfunction. Here, INS is linked to familial dilated cardiomyopathy.